# EDGAR Filing Document

**Accession Number:** 0000719135
**File Stem:** 0001493152-25-027481
**Filing Date:** 2025-12
**Character Count:** 8907
**Document Hash:** 402c8c248a621a3bef3e7d86a25855ba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-027481.hdr.sgml**: 20251212

**ACCESSION NUMBER**: 0001493152-25-027481

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20251208

**ITEM INFORMATION**: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251212

**DATE AS OF CHANGE**: 20251212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Apyx Medical Corp
- **CENTRAL INDEX KEY:** 0000719135
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 112644611
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31885
- **FILM NUMBER:** 251568089

**BUSINESS ADDRESS:**
- **STREET 1:** 5115 ULMERTON ROAD
- **CITY:** CLEARWATER
- **STATE:** FL
- **ZIP:** 33760
- **BUSINESS PHONE:** 7273842323

**MAIL ADDRESS:**
- **STREET 1:** 5115 ULMERTON ROAD
- **CITY:** CLEARWATER
- **STATE:** FL
- **ZIP:** 33760

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BOVIE MEDICAL Corp
- **DATE OF NAME CHANGE:** 20150319

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BOVIE MEDICAL CORP
- **DATE OF NAME CHANGE:** 19990216

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AN CON GENETICS INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**December 8, 2025**

Date of Report (date of earliest event reported)

![](form8-k_001.jpg)

**APYX MEDICAL CORPORATION**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-31885** | **11-2644611** |
| (State or other jurisdiction<br> of incorporation or organization) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification No.) |

---

**5115 Ulmerton Road, Clearwater, Florida 33760**

(Address of principal executive offices, zip code)

**(727) 384-2323**

Registrant's telephone number, including area code

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.001 per share | APYX | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 5.03.** | **Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.** |

---

As previously reported, Apyx Medical Corporation (the "Company") held its Annual Meeting of Stockholders on August 7, 2025, at which the Company's stockholders approved an amendment to the Company's Certificate of Incorporation, as amended ("Certificate of Incorporation"), to remove Article EIGHTH in its entirety and replace it with "intentionally omitted." (the "Amendment").

On December 8, 2025, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect the Amendment.

For more information about the Amendment, see the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2025, the relevant portions of which are incorporated herein by reference. The information set forth herein is qualified in its entirety by reference to the complete text of the Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.** |

---

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 3.1 | [Certificate of Amendment to the Certificate of Incorporation of Apyx Medical Corporation.](ex3-1.htm) |
| 104 | Cover Page Interactive Data File embedded within the Inline XBRL document |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **APYX MEDICAL CORPORATION** | **APYX MEDICAL CORPORATION** |
| Date: December 12, 2025 | By: | */s/ Matthew Hill* |
|  | Name: | Matthew Hill |
|  | Title: | Chief Financial Officer, Secretary and Treasurer |

---

## Exhibit 3.1

**Exhibit 3.1**

**CERTIFICATE OF AMENDMENT**

**TO**

**CERTIFICATE OF INCORPORATION**

**OF**

**APYX MEDICAL CORPORATION**

Pursuant to § 242 of the General Corporation Law

of the State of Delaware

The undersigned, being the Chief Executive Officer of Apyx Medical Corporation, a corporation organized under the laws of the State of Delaware (the "Corporation"), hereby certifies:

1. The
 original Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on December
 3, 1982, a Certificate of Amendment of the Certificate of Incorporation was filed with the Secretary of State of the State of Delaware
 on February 15, 1983, a Certificate of Amendment of the Certificate of Incorporation was filed with the Secretary of State of the
 State of Delaware on March 22, 1983, a Certificate of Amendment of the Certificate of Incorporation was filed with the Secretary
 of State of the State of Delaware on December 23, 1987, a Certificate for Renewal and Revival of Charter was filed with the Secretary
 of State of the State of Delaware on March 16, 1993, a Certificate of Amendment of the Certificate of Incorporation was filed with
 the Secretary of State of the State of Delaware on September 8, 1998, a Certificate of Designation, Preferences and Rights of Series
 A Preferred Stock was filed with the Secretary of State of the State of Delaware on September 8, 1998, a Certificate of Amendment
 of the Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on September 14, 1998, a Certificate
 of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock was filed with the Secretary of State
 of the State of Delaware on March 16, 2015, a Certificate of Amendment of the Certificate of Incorporation was filed with the Secretary
 of State of the State of Delaware on October 10, 2017, a Certificate of Elimination of the Series A Convertible Preferred Stock and
 Series B Convertible Preferred Stock of the Corporation was filed with the Secretary of State of the State of Delaware on May 3,
 2018, and a Certificate of Amendment of the Certificate of Incorporation was filed with the Secretary of State of the State of Delaware
 on December 20, 2018.

2. Article
 EIGHTH of the Certificate of Incorporation is hereby amended by deleting same in its entirety
 and replacing same with:

"Article EIGHTH: Intentionally Omitted."

3. The
 foregoing amendment was duly adopted in accordance with the provisions of Section 242 of
 the General Corporation Law of the State of Delaware.

\* \* \* \* \*

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to the Certificate of Incorporation of Apyx Medical Corporation to be signed by its Chief Executive Officer, this 8<sup>th</sup> day of December, 2025, who acknowledges that the foregoing is the act and deed of the Corporation and that the facts stated herein are true.

---

| | |
|:---|:---|
| **APYX MEDICAL CORPORATION** | **APYX MEDICAL CORPORATION** |
| By: | */s/ Charlie Goodwin* |
| Name: | Charlie Goodwin |
| Title: | Chief Executive Officer |

---